Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005856 | cytoskeleton | 5 | 2 |
GO:0005930 | axoneme | 2 | 2 |
GO:0015630 | microtubule cytoskeleton | 6 | 2 |
GO:0043226 | organelle | 2 | 3 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0005929 | cilium | 4 | 1 |
GO:0031514 | motile cilium | 5 | 1 |
GO:0042995 | cell projection | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 1 |
Related structures:
AlphaFold database: Q4QCQ4
Term | Name | Level | Count |
---|---|---|---|
GO:0000226 | microtubule cytoskeleton organization | 3 | 2 |
GO:0000281 | mitotic cytokinesis | 4 | 2 |
GO:0000910 | cytokinesis | 3 | 2 |
GO:0001539 | cilium or flagellum-dependent cell motility | 3 | 2 |
GO:0001578 | microtubule bundle formation | 4 | 2 |
GO:0003341 | cilium movement | 4 | 2 |
GO:0006996 | organelle organization | 4 | 2 |
GO:0007010 | cytoskeleton organization | 5 | 2 |
GO:0007017 | microtubule-based process | 2 | 2 |
GO:0007018 | microtubule-based movement | 3 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0022402 | cell cycle process | 2 | 2 |
GO:0022607 | cellular component assembly | 4 | 2 |
GO:0035082 | axoneme assembly | 5 | 2 |
GO:0048870 | cell motility | 2 | 2 |
GO:0060285 | cilium-dependent cell motility | 4 | 2 |
GO:0060294 | cilium movement involved in cell motility | 5 | 2 |
GO:0061640 | cytoskeleton-dependent cytokinesis | 4 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
GO:1903047 | mitotic cell cycle process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 2 |
GO:0005515 | protein binding | 2 | 2 |
GO:0008017 | microtubule binding | 5 | 2 |
GO:0008092 | cytoskeletal protein binding | 3 | 2 |
GO:0015631 | tubulin binding | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 184 | 186 | PF00082 | 0.253 |
CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.301 |
CLV_PCSK_KEX2_1 | 401 | 403 | PF00082 | 0.333 |
CLV_PCSK_KEX2_1 | 448 | 450 | PF00082 | 0.364 |
CLV_PCSK_PC1ET2_1 | 184 | 186 | PF00082 | 0.253 |
CLV_PCSK_PC1ET2_1 | 226 | 228 | PF00082 | 0.360 |
CLV_PCSK_PC1ET2_1 | 401 | 403 | PF00082 | 0.333 |
CLV_PCSK_PC1ET2_1 | 448 | 450 | PF00082 | 0.364 |
CLV_PCSK_SKI1_1 | 255 | 259 | PF00082 | 0.311 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.505 |
CLV_PCSK_SKI1_1 | 401 | 405 | PF00082 | 0.320 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.331 |
DOC_CYCLIN_RxL_1 | 44 | 53 | PF00134 | 0.334 |
DOC_CYCLIN_yCln2_LP_2 | 45 | 51 | PF00134 | 0.365 |
DOC_MAPK_DCC_7 | 166 | 174 | PF00069 | 0.253 |
DOC_MAPK_MEF2A_6 | 166 | 174 | PF00069 | 0.253 |
DOC_MAPK_RevD_3 | 170 | 185 | PF00069 | 0.253 |
DOC_PP1_RVXF_1 | 15 | 21 | PF00149 | 0.320 |
DOC_USP7_MATH_1 | 237 | 241 | PF00917 | 0.325 |
DOC_USP7_MATH_1 | 390 | 394 | PF00917 | 0.380 |
DOC_USP7_MATH_1 | 467 | 471 | PF00917 | 0.435 |
DOC_USP7_MATH_1 | 69 | 73 | PF00917 | 0.412 |
DOC_USP7_UBL2_3 | 401 | 405 | PF12436 | 0.339 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.360 |
DOC_WW_Pin1_4 | 195 | 200 | PF00397 | 0.422 |
DOC_WW_Pin1_4 | 279 | 284 | PF00397 | 0.315 |
DOC_WW_Pin1_4 | 386 | 391 | PF00397 | 0.490 |
DOC_WW_Pin1_4 | 488 | 493 | PF00397 | 0.360 |
LIG_14-3-3_CanoR_1 | 185 | 194 | PF00244 | 0.268 |
LIG_14-3-3_CanoR_1 | 455 | 461 | PF00244 | 0.324 |
LIG_14-3-3_CanoR_1 | 67 | 75 | PF00244 | 0.410 |
LIG_Actin_WH2_2 | 169 | 186 | PF00022 | 0.253 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.437 |
LIG_BRCT_BRCA1_1 | 101 | 105 | PF00533 | 0.300 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.310 |
LIG_FHA_1 | 324 | 330 | PF00498 | 0.301 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.470 |
LIG_FHA_2 | 138 | 144 | PF00498 | 0.268 |
LIG_FHA_2 | 188 | 194 | PF00498 | 0.268 |
LIG_FHA_2 | 21 | 27 | PF00498 | 0.253 |
LIG_FHA_2 | 495 | 501 | PF00498 | 0.386 |
LIG_FHA_2 | 7 | 13 | PF00498 | 0.427 |
LIG_LIR_Apic_2 | 385 | 390 | PF02991 | 0.354 |
LIG_LIR_Apic_2 | 488 | 492 | PF02991 | 0.498 |
LIG_LIR_LC3C_4 | 245 | 248 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 251 | 256 | PF02991 | 0.301 |
LIG_LIR_Nem_3 | 9 | 13 | PF02991 | 0.507 |
LIG_MYND_1 | 415 | 419 | PF01753 | 0.318 |
LIG_MYND_3 | 414 | 418 | PF01753 | 0.305 |
LIG_Pex14_1 | 147 | 151 | PF04695 | 0.253 |
LIG_Pex14_2 | 253 | 257 | PF04695 | 0.294 |
LIG_PTB_Apo_2 | 476 | 483 | PF02174 | 0.401 |
LIG_SH2_CRK | 437 | 441 | PF00017 | 0.442 |
LIG_SH2_NCK_1 | 301 | 305 | PF00017 | 0.254 |
LIG_SH2_SRC | 413 | 416 | PF00017 | 0.454 |
LIG_SH2_STAP1 | 437 | 441 | PF00017 | 0.442 |
LIG_SH2_STAP1 | 494 | 498 | PF00017 | 0.375 |
LIG_SH2_STAT3 | 505 | 508 | PF00017 | 0.511 |
LIG_SH2_STAT5 | 151 | 154 | PF00017 | 0.293 |
LIG_SH2_STAT5 | 301 | 304 | PF00017 | 0.329 |
LIG_SH2_STAT5 | 319 | 322 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 387 | 390 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 413 | 416 | PF00017 | 0.454 |
LIG_SH2_STAT5 | 432 | 435 | PF00017 | 0.293 |
LIG_SH3_3 | 173 | 179 | PF00018 | 0.253 |
LIG_SH3_3 | 409 | 415 | PF00018 | 0.339 |
LIG_SH3_3 | 420 | 426 | PF00018 | 0.387 |
LIG_SUMO_SIM_par_1 | 47 | 53 | PF11976 | 0.335 |
LIG_TRAF2_1 | 71 | 74 | PF00917 | 0.430 |
LIG_WRC_WIRS_1 | 7 | 12 | PF05994 | 0.495 |
MOD_CK1_1 | 321 | 327 | PF00069 | 0.377 |
MOD_CK1_1 | 389 | 395 | PF00069 | 0.485 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.445 |
MOD_CK2_1 | 137 | 143 | PF00069 | 0.253 |
MOD_CK2_1 | 20 | 26 | PF00069 | 0.465 |
MOD_CK2_1 | 467 | 473 | PF00069 | 0.430 |
MOD_CK2_1 | 494 | 500 | PF00069 | 0.394 |
MOD_CK2_1 | 6 | 12 | PF00069 | 0.495 |
MOD_CK2_1 | 68 | 74 | PF00069 | 0.412 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.298 |
MOD_GlcNHglycan | 320 | 323 | PF01048 | 0.398 |
MOD_GlcNHglycan | 366 | 369 | PF01048 | 0.365 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.305 |
MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.356 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.286 |
MOD_GSK3_1 | 302 | 309 | PF00069 | 0.432 |
MOD_GSK3_1 | 386 | 393 | PF00069 | 0.479 |
MOD_GSK3_1 | 467 | 474 | PF00069 | 0.503 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.324 |
MOD_N-GLC_1 | 69 | 74 | PF02516 | 0.401 |
MOD_N-GLC_2 | 479 | 481 | PF02516 | 0.321 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.315 |
MOD_NEK2_1 | 201 | 206 | PF00069 | 0.499 |
MOD_NEK2_1 | 323 | 328 | PF00069 | 0.300 |
MOD_NEK2_1 | 471 | 476 | PF00069 | 0.470 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.428 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.359 |
MOD_NEK2_2 | 179 | 184 | PF00069 | 0.253 |
MOD_PIKK_1 | 121 | 127 | PF00454 | 0.253 |
MOD_PIKK_1 | 83 | 89 | PF00454 | 0.467 |
MOD_PKA_2 | 364 | 370 | PF00069 | 0.326 |
MOD_Plk_1 | 179 | 185 | PF00069 | 0.253 |
MOD_Plk_4 | 201 | 207 | PF00069 | 0.390 |
MOD_Plk_4 | 494 | 500 | PF00069 | 0.379 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.288 |
MOD_ProDKin_1 | 195 | 201 | PF00069 | 0.416 |
MOD_ProDKin_1 | 279 | 285 | PF00069 | 0.310 |
MOD_ProDKin_1 | 386 | 392 | PF00069 | 0.484 |
MOD_ProDKin_1 | 488 | 494 | PF00069 | 0.358 |
MOD_SUMO_for_1 | 447 | 450 | PF00179 | 0.351 |
MOD_SUMO_for_1 | 463 | 466 | PF00179 | 0.370 |
MOD_SUMO_rev_2 | 220 | 225 | PF00179 | 0.313 |
TRG_DiLeu_BaEn_1 | 242 | 247 | PF01217 | 0.293 |
TRG_DiLeu_BaEn_1 | 284 | 289 | PF01217 | 0.310 |
TRG_DiLeu_BaLyEn_6 | 213 | 218 | PF01217 | 0.303 |
TRG_DiLeu_BaLyEn_6 | 379 | 384 | PF01217 | 0.341 |
TRG_DiLeu_BaLyEn_6 | 416 | 421 | PF01217 | 0.310 |
TRG_DiLeu_BaLyEn_6 | 45 | 50 | PF01217 | 0.318 |
TRG_ENDOCYTIC_2 | 437 | 440 | PF00928 | 0.448 |
TRG_ER_diArg_1 | 17 | 20 | PF00400 | 0.411 |
TRG_Pf-PMV_PEXEL_1 | 4 | 8 | PF00026 | 0.400 |
TRG_Pf-PMV_PEXEL_1 | 47 | 52 | PF00026 | 0.327 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE96 | Leptomonas seymouri | 94% | 100% |
A0A0S4J9K3 | Bodo saltans | 81% | 100% |
A0A1X0NXK0 | Trypanosomatidae | 85% | 99% |
A0A3Q8IEY0 | Leishmania donovani | 99% | 100% |
A0A3R7K990 | Trypanosoma rangeli | 85% | 99% |
A4HYY3 | Leishmania infantum | 99% | 100% |
B6HJ92 | Penicillium rubens (strain ATCC 28089 / DSM 1075 / NRRL 1951 / Wisconsin 54-1255) | 23% | 92% |
C9ZIJ0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 83% | 99% |
E9AIJ7 | Leishmania braziliensis | 96% | 78% |
E9AUS9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
O35345 | Mus musculus | 21% | 95% |
O60684 | Homo sapiens | 21% | 95% |
O75602 | Homo sapiens | 63% | 100% |
P52293 | Mus musculus | 21% | 96% |
Q0V7M0 | Bos taurus | 21% | 95% |
Q5RBV0 | Pongo abelii | 21% | 95% |
Q5ZML1 | Gallus gallus | 21% | 95% |
Q6C5Y8 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 25% | 89% |
Q9JLI7 | Mus musculus | 63% | 100% |
V5D560 | Trypanosoma cruzi | 86% | 99% |